Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma

Summary

RATIONALE: Vaccines made from a person's white blood cells and tumor cells may help the body build an effective immune response to kill tumor cells. Giving vaccine therapy after surgery may be a more effective treatment for malignant glioma. PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in treating young patients who are undergoing surgery for malignant glioma.

Timeline

Start

2005-01

Primary completion

2009-10

Completion

2010-03

Drugs

Indications